全文获取类型
收费全文 | 20391篇 |
免费 | 1709篇 |
国内免费 | 275篇 |
专业分类
耳鼻咽喉 | 140篇 |
儿科学 | 2620篇 |
妇产科学 | 550篇 |
基础医学 | 1426篇 |
口腔科学 | 54篇 |
临床医学 | 3170篇 |
内科学 | 3137篇 |
皮肤病学 | 60篇 |
神经病学 | 475篇 |
特种医学 | 377篇 |
外科学 | 693篇 |
综合类 | 3692篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 2396篇 |
眼科学 | 48篇 |
药学 | 2461篇 |
40篇 | |
中国医学 | 871篇 |
肿瘤学 | 163篇 |
出版年
2024年 | 68篇 |
2023年 | 376篇 |
2022年 | 817篇 |
2021年 | 1202篇 |
2020年 | 1383篇 |
2019年 | 724篇 |
2018年 | 706篇 |
2017年 | 779篇 |
2016年 | 866篇 |
2015年 | 888篇 |
2014年 | 1695篇 |
2013年 | 1700篇 |
2012年 | 1438篇 |
2011年 | 1480篇 |
2010年 | 1057篇 |
2009年 | 914篇 |
2008年 | 823篇 |
2007年 | 832篇 |
2006年 | 750篇 |
2005年 | 571篇 |
2004年 | 506篇 |
2003年 | 460篇 |
2002年 | 277篇 |
2001年 | 233篇 |
2000年 | 170篇 |
1999年 | 165篇 |
1998年 | 132篇 |
1997年 | 130篇 |
1996年 | 132篇 |
1995年 | 109篇 |
1994年 | 91篇 |
1993年 | 83篇 |
1992年 | 81篇 |
1991年 | 68篇 |
1990年 | 56篇 |
1989年 | 52篇 |
1988年 | 56篇 |
1987年 | 53篇 |
1986年 | 44篇 |
1985年 | 58篇 |
1984年 | 55篇 |
1983年 | 29篇 |
1982年 | 46篇 |
1981年 | 45篇 |
1980年 | 33篇 |
1979年 | 25篇 |
1978年 | 21篇 |
1977年 | 15篇 |
1976年 | 17篇 |
1975年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
6.
Olutobi Babatope Ojuawo Olufemi Olumuyiwa Desalu Ademola Emmanuel Fawibe Ayotade Boluwatife Ojuawo Adeniyi Olatunji Aladesanmi Christopher Muyiwa Opeyemi Mosunmoluwa Obafemi Adio Abdulraheem Olayemi Jimoh Dele Ohinoyi Amadu Abayomi Fadeyi Kazeem Alakija Salami 《African health sciences》2020,20(4):1655
BackgroundThe optimal management of community acquired pneumonia (CAP) depends on the clinical and microbiological profile in the locality.ObjectivesTo determine the clinical and microbiological profile of patients admitted with CAP in Ilorin, Nigeria.MethodsOne hundred and two consenting consecutively selected patients with clinical and radiologic confirmation of CAP were recruited in 12 months. The socio-demographic, physical examination and laboratory/radiologic parameters were documented in a questionnaire. Microbiological evaluation of their sputum was done and blood samples were taken for complete blood count, culture, serum urea and serological evaluation for atypical bacteria and some viral pathogens.ResultsCAP constituted 5.9% of the total medical admissions during the one-year study period. The mean age of the patients was 49 ± 22 years with the largest frequency in those aged 65 years and above. The commonest symptoms were shortness of breath (96.1%) and cough (94.1%), with a median duration of 3 days from symptom onset to admission. Systemic hypertension was the commonest comorbid illness (25/102; 24.5%). Klebsiella pneumoniae was the predominant pathogen isolated (20/102; 28.1%). The susceptible antibiotics were Imipenem, Ceftazidime and Ceftriaxone. Intra-hospital mortality was 17.6%. CURB – 65 score of ≥ 2 and the presence of complications of CAP were the independent predictors of mortality.ConclusionCAP constitutes a significant disease burden in Ilorin, Nigeria. Typical bacteria accounted for over half of the pathogens isolated from the patients with gram negative agents predominating. This highlights a possible shift in the microbiological profile which could guide empirical treatment. 相似文献
7.
8.
新型冠状病毒肺炎(新冠肺炎)对人民的生命健康造成了巨大的威胁。在新冠肺炎疫情下,如何应对肝胆外科肝癌患者的门诊筛查、病房管理以及安全地实施肝癌手术,都是对肝胆外科医师提出的新挑战。我们认为,该病的临床处置应在筛查新冠肺炎的前提下,遵循正规操作流程,做好充分防护。对于需要急诊治疗但无法排除新冠肺炎的肝癌患者,须综合考虑患者的病情严重程度、手术方式及手术室条件,慎重制定个体化治疗方案。整个诊疗过程必须遵从既保证患者的安全及疗效,又要降低医护人员感染风险的原则。 相似文献
9.
10.